Identifying Patients in Whom the Follow-Up Scheme after Robot-Assisted Radical Prostatectomy Could Be Optimized in the First Year after Surgery: Reducing Healthcare Burden.
Hans VeermanSophia H van der GraafDennie MeijerMarinus J HagensCorinne N TillierPim J van LeeuwenHenk G van der PoelAndré N VisPublished in: Biomedicines (2023)
Patients with an unmeasurable PSA level at 3-4 months after RARP may not need to be retested until 12 months of follow-up, as almost 100% of patients will not have the biochemically recurrent disease at 5-8 months of follow-up. This will reduce PSA testing substantially at the cost of hardly any missed patients with recurrent disease.